Just a moment, the page is loading...
The Supported Studies Programme
Login
GSK.com
Create / update profile
Submit your proposal
My proposals
User guidance
Contact GSK
View All Selected
Clear All
For the latest updates on GSK’s response to COVID-19, please
click here
.
Specialty
Timelines
Submit Investigator Sponsored Study proposals for clinical research using niraparib, dostarlimab, and/or TSR-022 here
[Chronic Hepatitis B (CHB) Supported Studies Committee. Last updated in May 2026]
• Understanding low diagnosis rates in CHB, impact to outcomes and opportunities to improve.
• Measuring the impact of a functional cure on the risk of hepatitis B virus (HBV) transmission.
• Understanding the impact of functional cure in subpopulations in chronic hepatitis B at greatest need for improved outcomes (e.g. those at most risk for hepatocellular carcinoma).
• Optimizing the long-term management and monitoring of patients who have achieved functional cure.
To help us verify your identity, a validation code will be sent to you.
Phone Number (By providing your phone number, you agree to receive text messages. Message and data rates may apply.)
Email Address (Code will be sent via email. If you don't see the email in your inbox, please check your spam folder.)
Enter code here
Terms of use
Accessibility
Cookie policy
Privacy
© 2001-2026 GlaxoSmithKline plc. All rights reserved. Registered in England and Wales No. 3888792.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.